- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01104103
Effectiveness Study of the BOA(R)-Constricting IV Band
July 16, 2012 updated by: Richard Bradley, The University of Texas Health Science Center, Houston
The BOA(R)-Constricting IV Band: A Single Blind, Cohort Study of Effectiveness
The purpose of this study is to determine whether the BOA(R)-Constricting IV Band is superior to standard methods for starting an IV.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
We will test the hypothesis that paramedics and nurses treating in- and out-of-hospital patients with a BOA(R)-Constricting IV Band, compared to paramedics using standard treatment, will have better success rates for peripheral IV access.
Study Type
Interventional
Enrollment (Actual)
467
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77002
- Houston Fire Department
-
Houston, Texas, United States, 77030-1501
- Memorial Hermann Hospital-Texas Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Paramedics employed by the City of Houston or nurses employed by Memorial Hermann Hospital - Texas Medical Center
- Agree to participate through written consent process
Exclusion Criteria:
- City of Houston paramedics and Memorial Hermann Hospital - Texas Medical Center nurses who do not provide written informed consent to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BOA(R)
Nurse or paramedic uses the BOA(R)-Constricting IV Band to attempt placement of an upper extremity IV in an adult
|
Device applied in accordance with manufacturer's instructions
Other Names:
|
|
Active Comparator: Standard care
Nurse or paramedic uses standard IV starting technique in the upper extremity of adults
|
Standard therapy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Success
Time Frame: five minutes (average)
|
This outcome will measure self-reported success at starting the peripheral intravenous lines in the upper extremity of adults.
Success is defined as an IV line through which blood may be aspirated and flushes freely without evidence of fluid extravasation.
To be successful, the IV must be placed within a maximum of three attempts.
We will report the number and percentage of patients with successful for both therapies.
|
five minutes (average)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
First Stick Success
Time Frame: Five minutes (average)
|
This outcome will report the number of IV attempts as defined by the tip of the needle piercing the skin.
The results for each IV attempt will be an ordinal number between one and three.
We will compare the number and percentage of patients in each group (1, 2, or 3 sticks) between the two therapies.
|
Five minutes (average)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Richard N Bradley, M.D., The University of Texas Health Science Center, Houston
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Black KJ, Pusic MV, Harmidy D, McGillivray D. Pediatric intravenous insertion in the emergency department: bevel up or bevel down? Pediatr Emerg Care. 2005 Nov;21(11):707-11. doi: 10.1097/01.pec.0000186422.77140.1f.
- Meier J, Schreier E. Human plasma levels of some anti-migraine drugs. Headache. 1976 Jul;16(3):96-104. doi: 10.1111/j.1526-4610.1976.hed1603096.x. No abstract available.
- Jacobson AF, Winslow EH. Variables influencing intravenous catheter insertion difficulty and failure: an analysis of 339 intravenous catheter insertions. Heart Lung. 2005 Sep-Oct;34(5):345-59. doi: 10.1016/j.hrtlng.2005.04.002.
- Lapostolle F, Catineau J, Garrigue B, Monmarteau V, Houssaye T, Vecci I, Treoux V, Hospital B, Crocheton N, Adnet F. Prospective evaluation of peripheral venous access difficulty in emergency care. Intensive Care Med. 2007 Aug;33(8):1452-7. doi: 10.1007/s00134-007-0634-y. Epub 2007 Jun 7.
- Pons PT, Moore EE, Cusick JM, Brunko M, Antuna B, Owens L. Prehospital venous access in an urban paramedic system--a prospective on-scene analysis. J Trauma. 1988 Oct;28(10):1460-3. doi: 10.1097/00005373-198810000-00009.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Actual)
May 1, 2010
Study Completion (Actual)
May 1, 2010
Study Registration Dates
First Submitted
April 9, 2010
First Submitted That Met QC Criteria
April 13, 2010
First Posted (Estimate)
April 15, 2010
Study Record Updates
Last Update Posted (Estimate)
August 20, 2012
Last Update Submitted That Met QC Criteria
July 16, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NAR UTH 001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Catheterization, Peripheral
-
Qilu Hospital of Shandong UniversityUnknownCatheterization, Peripheral | Catheterization, Central VenousChina
-
University of CalgaryRecruitingCatheterization, PeripheralCanada
-
Escola Superior de Enfermagem de CoimbraInstituto Português Oncologia de Coimbra Francisco Gentil E. P. E.CompletedCatheterization, PeripheralPortugal
-
Lahey ClinicTerminatedCatheterization, PeripheralUnited States
-
Saglik Bilimleri Universitesi Gazi Yasargil Training...CompletedCatheterization, PeripheralTurkey
-
Samsung Medical CenterCompletedCatheterization, PeripheralKorea, Republic of
-
Hospital San Carlos, MadridFoundation for Biomedical Research and InnovationCompletedCatheterization, PeripheralSpain
-
Poitiers University HospitalRecruiting
-
Embrace Medical Ltd.CompletedCatheterization, Peripheral VenousDominican Republic
-
University Hospital, BordeauxCompletedPeripheral Venous CatheterizationFrance
Clinical Trials on BOA(R)-Constricting IV Band
-
Herlev HospitalCompletedPostoperative Nausea and Vomiting | Acupressure Point P6Denmark
-
National Institute of Mental Health (NIMH)WithdrawnUnipolar DepressionUnited States
-
State University of New York - Downstate Medical...TerminatedDiabetes Mellitus | End-Stage Renal DiseaseUnited States
-
National Institute of Mental Health (NIMH)Active, not recruitingBipolar Disorder | Major Depressive Disorder | Unipolar Major DepressionUnited States
-
Johann Wolfgang Goethe University HospitalWithdrawnSDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV InhibitorsGermany
-
University of MinnesotaCompletedPain | Pain, Acute | AnesthesiaUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Thailand, Korea, Republic of, United Kingdom, China, Germany, Israel, Mexico, Argentina, Brazil, Colombia, Puerto Rico, Russian Federation
-
The Second Artillery General HospitalHunan Rui Kang Tong technology development co., LTDUnknownIschemic Cerebrovascular Accident
-
Henan Cancer HospitalNot yet recruitingLymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell